Cardiovascular toxicities associated with immune checkpoint inhibitors.

Hu JR, Florido R, Lipson EJ, Naidoo J, Ardehali R, Tocchetti CG, Lyon AR, Padera RF, Johnson DB, Moslehi J
Cardiovasc Res. 2019 115 (5): 854-868

PMID: 30715219 · PMCID: PMC6452314 · DOI:10.1093/cvr/cvz026

MeSH Terms (12)

Animals Antineoplastic Agents, Immunological Cardiotoxicity Cardiovascular Diseases Humans Myocarditis Neoplasms Pericarditis Prognosis Risk Assessment Risk Factors Vasculitis

Connections (2)

This publication is referenced by other Labnodes entities:

Links